Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multicenter, Real-World Study.

Milena Velojic-GolubovicVojislav CiricMarija DimitrijevicTijana KovicMilica MiticBiljana OlujicNatasa PevacSasa RadenkovicDanijela RadojkovicSelena VukadinovicDjordje S Popovic

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)

Sanofi Serbia.

Keyphrases

type diabetes
glycemic control
cross sectional
clinical trial
adipose tissue
skeletal muscle
insulin resistance
weight loss
double blind